Výsledky vyhledávání - "Leucovorin/therapeutic use"
-
1
Autoři: a další
Přispěvatelé: a další
Zdroj: Ann Surg
Témata: neoadjuvant treatment, Male, Adult, adjuvant chemotherapy, FOLFIRINOX, Pancreatic neoplasm, prognostic score, Oxaliplatin/therapeutic use, Irinotecan/therapeutic use, Surgery, anesthesiology, intensive care, radiology, Leucovorin, Fluorouracil/therapeutic use, Irinotecan, Risk Assessment, Pancreatectomy, SDG 3 - Good Health and Well-being, Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Pancreatic Neoplasms/mortality, Humans, Adjuvant, Retrospective Studies, Aged, Cancer och onkologi, Leucovorin/therapeutic use, Pancreatic Ductal/mortality, Kirurgi, Carcinoma, pancreatic neoplasm, Original Articles, Middle Aged, Prognosis, Neoadjuvant Therapy, Pancreatic Neoplasms, Oxaliplatin, Survival Rate, Chemotherapy, Adjuvant, Cancer and Oncology, Surgery, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Fluorouracil, Carcinoma, Pancreatic Ductal
Popis souboru: application/pdf
-
2
Autoři: a další
Zdroj: Ann Surg Oncol
Témata: Male, Adult, Leucovorin, Pancreatic Tumors, Middle Aged, Irinotecan, Prognosis, Deoxycytidine, Gemcitabine, FOLFIRINOX, Leucovorin/administration, Aged [MeSH], Pancreatic Neoplasms/pathology [MeSH], Deoxycytidine/administration, Oxaliplatin/therapeutic use [MeSH], Irinotecan/therapeutic use [MeSH], Neoadjuvant Therapy [MeSH], Male [MeSH], Adenocarcinoma/drug therapy [MeSH], Adenocarcinoma/pathology [MeSH], Pancreatectomy [MeSH], Pancreatic Neoplasms/surgery [MeSH], Fluorouracil/administration, Oxaliplatin/administration, Female [MeSH], Follow-Up Studies [MeSH], Leucovorin/therapeutic use [MeSH], Adult [MeSH], Humans [MeSH], Irinotecan/administration, Middle Aged [MeSH], Neoadjuvant, Pancreatic Neoplasms/drug therapy [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Gemcitabine [MeSH], Survival Rate [MeSH], Chemotherapy, Adjuvant [MeSH], Resectable pancreatic cancer, Adjuvant, Deoxycytidine/analogs, Prognosis [MeSH], Adenocarcinoma/mortality [MeSH], Adenocarcinoma/surgery [MeSH], Neoadjuvant Therapy, Pancreatic Neoplasms, Oxaliplatin, Survival Rate, 03 medical and health sciences, Pancreatectomy, 0302 clinical medicine, Chemotherapy, Adjuvant, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Fluorouracil, Aged, Follow-Up Studies
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38459418
https://repository.publisso.de/resource/frl:6502185 -
3
Autoři: a další
Přispěvatelé: a další
Zdroj: J Cancer Res Clin Oncol
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Journal of Cancer Research and Clinical Oncology, Vol 150, Iss 10, Pp 1-12 (2024)Témata: Delayed methotrexate elimination, Antimetabolites, Antineoplastic, Consensus, Other subheadings::Other subheadings::/therapeutic use, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Decisió de grup, Otros calificadores::Otros calificadores::/uso terapéutico, Leucovorin, Carboxypeptidases, Glucarpidase, Methotrexate pharmacokinetics, Methotrexate toxicity, Review, DISEASES::Neoplasms, Neoplasms, Antimetabòlits - Ús terapèutic, Humans, PSIQUIATRÍA Y PSICOLOGÍA::conducta y mecanismos de la conducta::psicología social::procesos de grupo::consenso, Antimetabolites, Antineoplastic/therapeutic use [MeSH], Europe [MeSH], Leucovorin/administration, Leucovorin/therapeutic use [MeSH], Antimetabolites, Antineoplastic/adverse effects [MeSH], Humans [MeSH], Recombinant Proteins/administration, gamma-Glutamyl Hydrolase/therapeutic use [MeSH], Antimetabolites, Antineoplastic/administration, Methotrexate/administration, Neoplasms/drug therapy [MeSH], Methotrexate/adverse effects [MeSH], Methotrexate/therapeutic use [MeSH], Consensus [MeSH], RC254-282, PSYCHIATRY AND PSYCHOLOGY::Behavior and Behavior Mechanisms::Psychology, Social::Group Processes::Consensus, Other subheadings::Other subheadings::Other subheadings::/drug therapy, Càncer - Tractament, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::antimetabolitos::antimetabolitos antineoplásicos, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, gamma-Glutamyl Hydrolase, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antimetabolites::Antimetabolites, Antineoplastic, Recombinant Proteins, Europe, Methotrexate, ENFERMEDADES::neoplasias
Popis souboru: application/pdf
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39356310
https://hdl.handle.net/11351/12270
https://doaj.org/article/723e1414c20948f49d0c4df2e2d91a29
https://repository.publisso.de/resource/frl:6499048
https://hdl.handle.net/11585/1007036
https://link.springer.com/article/10.1007/s00432-024-05945-6
https://doi.org/10.1007/s00432-024-05945-6 -
4
Autoři: a další
Přispěvatelé: a další
Zdroj: Ann Surg Oncol
Témata: Leucovorin / therapeutic use, Paclitaxel, 'chemotherapy', 'borderline resectable', 'locally advanced pancreatic cancer', Leucovorin, Pancreatic Tumors, Gemcitabine, Neoadjuvant Therapy, 3. Good health, Pancreatic Neoplasms* / drug therapy, Oxaliplatin, Pancreatic Neoplasms, Pancreatic Neoplasms* / surgery, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Pancreatic Neoplasms* / pathology, Antineoplastic Combined Chemotherapy Protocols, Neoadjuvant Therapy / adverse effects, Humans, Multicenter Studies as Topic, Fluorouracil, Oxaliplatin / therapeutic use
Popis souboru: application/pdf
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37020094
-
5
Autoři: a další
Zdroj: J Cancer Res Clin Oncol
Témata: Male, Adult, 0301 basic medicine, ddc:610, Cross-Over Studies, Research, Leucovorin/administration, Oxaliplatin, Aged [MeSH], Pancreatic Neoplasms/pathology [MeSH], Progression-Free Survival [MeSH], Oxaliplatin/therapeutic use [MeSH], Metastatic, Camptothecin/analogs, Irinotecan/therapeutic use [MeSH], Camptothecin/therapeutic use [MeSH], FOLFIRI, Male [MeSH], Camptothecin/administration, Pancreatic cancer, Fluorouracil/administration, Oxaliplatin/administration, Female [MeSH], Fluoropyrimidine, Leucovorin/therapeutic use [MeSH], Adult [MeSH], Fluorouracil/therapeutic use [MeSH], Humans [MeSH], Irinotecan/administration, Middle Aged [MeSH], Pancreatic Neoplasms/drug therapy [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Cross-Over Studies [MeSH], Chemotherapy, Leucovorin, Middle Aged, Irinotecan, Progression-Free Survival, Pancreatic Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Camptothecin, Fluorouracil, Aged
Popis souboru: application/pdf
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38951245
https://repository.publisso.de/resource/frl:6501324 -
6
Autoři: a další
Přispěvatelé: a další
Zdroj: J Clin Oncol
Témata: Organoplatinum Compounds, Leucovorin, Fluorouracil / therapeutic use, Colonic Neoplasms* / pathology, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Colonic Neoplasms* / drug therapy, Chemotherapy, Humans, Adjuvant, Capecitabine, Neoplasm Staging, Leucovorin / therapeutic use, Organoplatinum Compounds* / therapeutic use, ORIGINAL REPORTS, Oxaliplatin* / therapeutic use, 3. Good health, Oxaliplatin, Capecitabine / therapeutic use, Chemotherapy, Adjuvant, Colonic Neoplasms, Fluorouracil
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35772045
-
7
Autoři: a další
Zdroj: JAMA Oncology
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)Témata: Male, Adult, Leucovorin/therapeutic use, Oxaliplatin/therapeutic use, Irinotecan/therapeutic use, Leucovorin, Middle Aged, Adenocarcinoma, Fluorouracil/therapeutic use, Irinotecan, Pancreatic Neoplasms, Oxaliplatin, SDG 3 - Good Health and Well-being, Adenocarcinoma/drug therapy, Pancreatic Neoplasms/drug therapy, Chemotherapy, Adjuvant, Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Humans, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Fluorouracil, Adjuvant, Retrospective Studies, Aged
Popis souboru: application/pdf
-
8
Autoři: a další
Přispěvatelé: a další
Zdroj: Journal of Cancer Research and Clinical Oncology. 149:1131-1143
Témata: Male, Camptothecin / therapeutic use, Leucovorin, Fluorouracil / therapeutic use, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Republic of Korea, Colonic Neoplasms* / drug therapy, Chemotherapy, Humans, Oxaliplatin / therapeutic use, Bevacizumab / therapeutic use, Leucovorin / therapeutic use, Rectal Neoplasms, Colorectal Neoplasms* / pathology, Rectal Neoplasms* / drug therapy, Anti-VEGF agents, Colorectal cancer, 3. Good health, Oxaliplatin, Bevacizumab, Colonic Neoplasms, Camptothecin, Acquired resistance, Fluorouracil, Colorectal Neoplasms
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35344080
-
9
Autoři: a další
Přispěvatelé: a další
Zdroj: Cancer Sci
Témata: Male, Fluorouracil / adverse effects, Camptothecin / therapeutic use, Leucovorin, Deoxycytidine, Colorectal Neoplasms / genetics, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Topoisomerase I Inhibitors / adverse effects, Fluorouracil / analogs & derivatives, Colorectal Neoplasms / mortality, XELIRI, Glucuronosyltransferase, irinotecan, Genotype, Aged, 80 and over, Deoxycytidine / adverse effects, capecitabine, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Middle Aged, Prognosis, Colorectal Neoplasms / drug therapy, Progression-Free Survival, 3. Good health, Bevacizumab, Treatment Outcome, Deoxycytidine / analogs & derivatives, Camptothecin / adverse effects, Female, Fluorouracil, Colorectal Neoplasms, Deoxycytidine / therapeutic use, Adult, Camptothecin / analogs & derivatives, colorectal cancer, Fluorouracil / therapeutic use, Colorectal Neoplasms / pathology, Young Adult, 03 medical and health sciences, Confidence Intervals, Humans, Aged, Bevacizumab / therapeutic use, Leucovorin / therapeutic use, Leucovorin / adverse effects, Original Articles, Glucuronosyltransferase / genetics, Camptothecin, UGT1A1, Topoisomerase I Inhibitors, Topoisomerase I Inhibitors / therapeutic use
Přístupová URL adresa: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.15092
https://pubmed.ncbi.nlm.nih.gov/34327766
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586680/
https://snucm.elsevierpure.com/en/publications/impact-of-ugt1a1-genotype-on-the-efficacy-and-safety-of-irinoteca
https://pure.fujita-hu.ac.jp/ja/publications/impact-of-ugt1a1-genotype-on-the-efficacy-and-safety-of-irinoteca
https://onlinelibrary.wiley.com/doi/10.1111/cas.15092
https://pubmed.ncbi.nlm.nih.gov/34327766/
https://www.ncbi.nlm.nih.gov/pubmed/34327766 -
10
Autoři: a další
Zdroj: Annals of Surgery, 274, 5, pp. 729-735
Témata: Male, Oxaliplatin/therapeutic use, Irinotecan/therapeutic use, SURGERY, IMPACT, Leucovorin, Netherlands/epidemiology, Antineoplastic Agents, Pancreas/pathology, Fluorouracil/therapeutic use, Irinotecan, 03 medical and health sciences, Pancreatectomy, 0302 clinical medicine, SDG 3 - Good Health and Well-being, QUALITY-OF-LIFE, Antineoplastic Combined Chemotherapy Protocols, Humans, Pancreatic Neoplasms/diagnosis, resection, Prospective Studies, Propensity Score, NEOADJUVANT THERAPY, Pancreas, BORDERLINE, Neoplasm Staging, Netherlands, Survival Rate/trends, OUTCOMES, Leucovorin/therapeutic use, Antineoplastic Agents/therapeutic use, ADENOCARCINOMA, Middle Aged, Radboudumc 14: Tumours of the digestive tract RIHS: Radboud Institute for Health Sciences, locally advanced pancreatic cancer, 3. Good health, Pancreatectomy/methods, FOLFIRINOX, Oxaliplatin, Pancreatic Neoplasms, Survival Rate, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Fluorouracil, Surgery - Radboud University Medical Center, Follow-Up Studies
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/34334641
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/239076
https://doi.org/10.1097/SLA.0000000000005120
https://pure.eur.nl/en/publications/74f5b12b-d076-4c09-9054-6462852b6612
https://doi.org/10.1097/SLA.0000000000005120
https://research.rug.nl/en/publications/879dd244-9b84-48da-b3fe-2dc2b8df7b87
https://doi.org/10.1097/SLA.0000000000005120
https://hdl.handle.net/11370/879dd244-9b84-48da-b3fe-2dc2b8df7b87
https://pubmed.ncbi.nlm.nih.gov/34334641/
https://research.rug.nl/en/publications/survival-benefit-associated-with-resection-of-locally-advanced-pa
https://pure.amsterdamumc.nl/en/publications/dba02f12-bfaa-421a-b159-fb3badf7fee1
https://doi.org/10.1097/SLA.0000000000005120
https://hdl.handle.net/2066/239076
https://repository.ubn.ru.nl//bitstream/handle/2066/239076/239076.pdf -
11
Autoři: a další
Zdroj: Clin Transl Oncol
Témata: CD4-Positive T-Lymphocytes, Male, Paclitaxel, Leucovorin, Forkhead Transcription Factors, CD8-Positive T-Lymphocytes, Middle Aged, Immune Checkpoint Proteins, Irinotecan, Deoxycytidine, 3. Good health, Oxaliplatin, Pancreatic Neoplasms, Brief Research Article, 03 medical and health sciences, 0302 clinical medicine, Albumins, FOLFIRINOX, Aged [MeSH], T-Lymphocytes, Regulatory/chemistry [MeSH], Gemcitabine, CD4-Positive T-Lymphocytes/drug effects [MeSH], Progression-Free Survival [MeSH], Albumins/therapeutic use [MeSH], CD8-Positive T-Lymphocytes/drug effects [MeSH], Forkhead Transcription Factors [MeSH], Immune Checkpoint Proteins/analysis [MeSH], Oxaliplatin/therapeutic use [MeSH], Programmed Cell Death 1 Receptor/drug effects [MeSH], Irinotecan/therapeutic use [MeSH], CD4-Positive T-Lymphocytes/chemistry [MeSH], Male [MeSH], Nab-paclitaxel, CD8-Positive T-Lymphocytes/chemistry [MeSH], Hepatitis A Virus Cellular Receptor 2/analysis [MeSH], Pancreatic cancer, Carcinoma, Pancreatic Ductal/immunology [MeSH], Female [MeSH], Leucovorin/therapeutic use [MeSH], Immune checkpoints, Fluorouracil/therapeutic use [MeSH], Humans [MeSH], Prospective Studies [MeSH], Middle Aged [MeSH], T-Lymphocytes, Regulatory/drug effects [MeSH], Pancreatic Neoplasms/drug therapy [MeSH], Programmed Cell Death 1 Receptor/analysis [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Pancreatic Neoplasms/immunology [MeSH], Carcinoma, Pancreatic Ductal/drug therapy [MeSH], Immune Checkpoint Proteins/drug effects [MeSH], Paclitaxel/therapeutic use [MeSH], Deoxycytidine/analogs, Pilot Projects [MeSH], Deoxycytidine/therapeutic use [MeSH], Regulatory T cells, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Fluorouracil, Hepatitis A Virus Cellular Receptor 2, Aged, Carcinoma, Pancreatic Ductal
Přístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s12094-021-02620-x.pdf
https://pubmed.ncbi.nlm.nih.gov/33876417
https://dialnet.unirioja.es/servlet/articulo?codigo=8064032
https://link.springer.com/content/pdf/10.1007/s12094-021-02620-x.pdf
https://link.springer.com/article/10.1007/s12094-021-02620-x
https://www.ncbi.nlm.nih.gov/pubmed/33876417
https://epub.ub.uni-muenchen.de/76493/
http://www.ncbi.nlm.nih.gov/pubmed/33876417
https://repository.publisso.de/resource/frl:6445608
https://epub.ub.uni-muenchen.de/76493/ -
12
Autoři: a další
Zdroj: Br J Cancer
Témata: Adult, metastatic colorectal cancer, Leucovorin, Cetuximab, Middle Aged, Article, Drug Administration Schedule, Progression-Free Survival, Intention to Treat Analysis, 3. Good health, Bevacizumab, 03 medical and health sciences, Genes, ras, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, cetuximab, Humans, Camptothecin, Fluorouracil, Biomarkers, Leucovorin/administration, Leucovorin/therapeutic use [MeSH], Aged [MeSH], Adult [MeSH], Fluorouracil/therapeutic use [MeSH], Humans [MeSH], Progression-Free Survival [MeSH], Colorectal Neoplasms/drug therapy [MeSH], Bevacizumab/therapeutic use [MeSH], Drug Administration Schedule [MeSH], Middle Aged [MeSH], Oncology, Camptothecin/analogs, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Intention to Treat Analysis [MeSH], Camptothecin/therapeutic use [MeSH], Cetuximab/therapeutic use [MeSH], Genes, ras [MeSH], Colorectal Neoplasms/pathology [MeSH], Colorectal Neoplasms/genetics [MeSH], Colorectal Neoplasms/mortality [MeSH], Colorectal Neoplasms, progression-free survival, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit, Aged
Přístupová URL adresa: https://www.nature.com/articles/s41416-020-01140-9.pdf
https://pubmed.ncbi.nlm.nih.gov/33154570
https://pubmed.ncbi.nlm.nih.gov/33154570/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851157
https://www.nature.com/articles/s41416-020-01140-9.pdf
https://europepmc.org/article/MED/33154570
https://www.nature.com/articles/s41416-020-01140-9
https://repository.publisso.de/resource/frl:6471412 -
13
Autoři: a další
Témata: Basal Ganglia/pathology Brain Diseases/*cerebrospinal fluid/diagnosis/enzymology DNA Mutational Analysis Decalcification, Pathologic/diagnosis Dyskinesias/diagnosis Female Fibroblasts/enzymology Folic Acid/*cerebrospinal fluid Humans Infant Infant, Newborn Intracellular Signaling Peptides and Proteins Leucovorin/therapeutic use Male Mental Retardation/diagnosis Microcephaly/diagnosis Muscle Hypertonia/diagnosis Phenotype Proteins/genetics Psychomotor Disorders/diagnosis Pterins/*cerebrospinal fluid/metabolism Seizures/diagnosis Syndrome Tomography, X-Ray Computed
Relation: Neurology; https://iris.unil.ch/handle/iris/73639; serval:BIB_5A343DC2A525; 000185187000011
Dostupnost: https://iris.unil.ch/handle/iris/73639
-
14
Autoři: a další
Přispěvatelé: a další
Zdroj: Cancer Sci
Témata: Adult, Male, 0301 basic medicine, Irinotecan / administration & dosage, Endpoint Determination, liposomal irinotecan, Leucovorin, Fluorouracil / therapeutic use, Adenocarcinoma, Irinotecan, 03 medical and health sciences, 0302 clinical medicine, Asian People, metastatic pancreatic cancer, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Humans, Fluorouracil / administration & dosage, Irinotecan / therapeutic use, Neoplasm Metastasis, NAPOLI-1, Aged, Leucovorin / therapeutic use, Aged, 80 and over, clinical trial, Pancreatic Neoplasms / drug therapy, Original Articles, Antineoplastic Combined Chemotherapy Protocols / administration & dosage, Leucovorin / administration & dosage, Middle Aged, Survival Analysis, 3. Good health, Asians, Pancreatic Neoplasms, Treatment Outcome, Adenocarcinoma / drug therapy, phase 3, Liposomes, Female, Fluorouracil, Asian subgroup
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/31789476
https://europepmc.org/article/PMC/PMC7004519
https://onlinelibrary.wiley.com/doi/10.1111/cas.14264
https://pubmed.ncbi.nlm.nih.gov/31789476/
https://snucm.elsevierpure.com/en/publications/liposomal-irinotecan-in-metastatic-pancreatic-adenocarcinoma-in-a
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004519/
https://s-space.snu.ac.kr/handle/10371/173033 -
15
Autoři: a další
Přispěvatelé: a další
Zdroj: Int J Cancer
Jongeneel, G, Klausch, T, van Erning, F N, Vink, G R, Koopman, M, Punt, C J A, Greuter, M J E & Coupé, V M H 2020, 'Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real-world data', International Journal of Cancer, vol. 146, no. 11, pp. 2968-2978. https://doi.org/10.1002/ijc.32629Témata: Male, Cancer Research, treatment effect, Organoplatinum Compounds, Leucovorin, Fluorouracil/therapeutic use, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Colonic Neoplasms/drug therapy, Organoplatinum Compounds/therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Journal Article, Humans, Comparative Study, Neoplasm Staging, Netherlands, Randomized Controlled Trials as Topic, Leucovorin/therapeutic use, real-world data, Research Support, Non-U.S. Gov't, randomized clinical trial, 3. Good health, adjuvant chemotherapy, colon cancer, Oncology, Chemotherapy, Adjuvant, Colonic Neoplasms, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Fluorouracil, Cancer Epidemiology, Chemotherapy, Adjuvant/methods
Popis souboru: application/pdf
Přístupová URL adresa: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.32629
https://pubmed.ncbi.nlm.nih.gov/31424568
https://europepmc.org/abstract/MED/31424568
https://www.narcis.nl/publication/RecordID/oai%3Apure.atira.dk%3Apublications%2F1a7dcc03-5942-42d8-8f7c-9dcfb6f2071f
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32629
https://www.ncbi.nlm.nih.gov/pubmed/31424568
https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.32629
https://research.vumc.nl/en/publications/estimating-adjuvant-treatment-effects-in-stage-ii-colon-cancer-co
https://research.vumc.nl/en/publications/1a7dcc03-5942-42d8-8f7c-9dcfb6f2071f
https://dspace.library.uu.nl/handle/1874/441785
https://pure.amsterdamumc.nl/en/publications/165b2c6c-92a5-495b-9c48-1858a2358c11
https://doi.org/10.1002/ijc.32629 -
16
Autoři: a další
Přispěvatelé: a další
Témata: Male, Oxaliplatin/therapeutic use, Irinotecan/therapeutic use, Locally advanced pancreatic cancer, Netherlands/epidemiology, Pancreas/pathology, Fluorouracil/therapeutic use, Journal Article, Humans, Pancreatic Neoplasms/diagnosis, Prospective Studies, resection, Propensity Score, Neoplasm Staging, Survival Rate/trends, Leucovorin/therapeutic use, Antineoplastic Agents/therapeutic use, Middle Aged, Resection, locally advanced pancreatic cancer, FOLFIRINOX, Pancreatectomy/methods, Multicenter Study, Female, Surgery, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Follow-Up Studies
Popis souboru: application/pdf
Přístupová URL adresa: https://dspace.library.uu.nl/handle/1874/444533
-
17
Autoři: a další
Zdroj: the PETACC8 Study Investigators 2017, ' Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX ', European Journal of Cancer, vol. 82, pp. 16-24 . https://doi.org/10.1016/j.ejca.2017.04.025
Témata: Adult, Male, Organoplatinum Compounds, Medizin, Leucovorin, Fluorouracil/therapeutic use, Prospective cohort study, Biomarker, Colorectal carcinoma, Immune response, Biomarkers, Tumor/analysis, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, 0302 clinical medicine, Organoplatinum Compounds/therapeutic use, colorectal carcinoma, Predictive Value of Tests, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, Tumor/analysis, Prospective cohort study, Tumor-Infiltrating, Lymphocytes, Prospective Studies, Aged, Leucovorin/therapeutic use, Middle Aged, Prognosis, Survival Analysis, 3. Good health, Colonic Neoplasms, Multivariate Analysis, Oncology, Cancer Research, Colonic Neoplasms/diagnosis, Lymphocytes/pathology, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Fluorouracil, Biomarkers
Popis souboru: application/pdf
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/28651158
https://hal-univ-tlse3-archives-ouvertes-fr.ezproxy.u-pec.fr/hal-01579009v1
https://www.sciencedirect.com/science/article/pii/S0959804917309528
https://hal.archives-ouvertes.fr/hal-01579009
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/260465/Details
http://www.sciencedirect.com/science/article/pii/S0959804917309528
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01579009
https://www.sciencedirect.com/science/article/pii/S0959804917309528?via=ihub
https://doi.org/10.1016/j.ejca.2017.04.025
https://hdl.handle.net/10281/260499
https://portal.findresearcher.sdu.dk/da/publications/b6ba4204-b605-499a-a996-7030914bc87f
https://doi.org/10.1016/j.ejca.2017.04.025
https://portal.findresearcher.sdu.dk/da/publications/b6ba4204-b605-499a-a996-7030914bc87f
http://www.journals.elsevier.com/european-journal-of-cancer/
https://doi.org/10.1016/j.ejca.2017.04.025
https://hdl.handle.net/2318/1652484
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85021288157
https://doi.org/10.1016/j.ejca.2017.04.025
https://www.ncbi.nlm.nih.gov/pubmed/28651158 -
18
Autoři: a další
Přispěvatelé: a další
Zdroj: Oncotarget
Témata: Male, 0301 basic medicine, Substances, Organoplatinum Compounds, diagnosis, Supplementary concept, Leucovorin, Fluorouracil/adverse effects, Organoplatinum Compounds/therapeutic use, Colorectal Neoplasms/mortality, Antineoplastic Combined Chemotherapy Protocols, Cluster Analysis, Adjuvant, Colorectal, 0303 health sciences, Tumor, Leucovorin/therapeutic use, Colorectal Neoplasms/drug therapy, Middle Aged, Prognosis, Leucovorin/adverse effects, 3. Good health, Treatment Outcome, colon cancer, Chemotherapy, Adjuvant, Female, consensus molecular subtype, Fluorouracil, Colorectal Neoplasms, Research Paper, Adult, mRNA expression-based molecular classification, Fluorouracil/therapeutic use, 03 medical and health sciences, Folfox protocol, Biomarkers, Tumor, Chemotherapy, Humans, Organoplatinum Compounds/adverse effects, Aged, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Gene Expression Profiling, DNA microarray, Computational Biology, molecular subtype, Colorectal Neoplasms/genetics, Survival Analysis, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Transcriptome, Biomarkers
Popis souboru: application/pdf
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/28455965
https://www.europepmc.org/articles/PMC5503619/
https://ir.ymlib.yonsei.ac.kr/bitstream/22282913/160269/1/T201701925.pdf
https://ir.ymlib.yonsei.ac.kr/handle/22282913/160269
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503619
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503619
https://www.oncotarget.com/fulltext/17023 -
19
Autoři: a další
Přispěvatelé: a další
Témata: adjuvant chemotherapy, colon cancer, randomized clinical trial, real-world data, treatment effect, Organoplatinum Compounds/therapeutic use, Humans, Male, Chemotherapy, Adjuvant/methods, Randomized Controlled Trials as Topic, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Disease-Free Survival, Fluorouracil/therapeutic use, Netherlands, Female, Neoplasm Staging, Colonic Neoplasms/drug therapy, Leucovorin/therapeutic use, Oncology, Cancer Research, Research Support, Non-U.S. Gov't, Journal Article, Comparative Study
Popis souboru: application/pdf
Dostupnost: https://dspace.library.uu.nl/handle/1874/441785
-
20
Autoři: a další
Zdroj: Craig, Z, Swain, J, Batman, E, Wadsley, J, Reed, N, Faluyi, O, Cave, J, Rohini, S, Chau, I, Wall, L, Lamarca, A, Hubner, R, Mansoor, W, Sarker, D, Meyer, T, Cairns, D A, Howard, H, Valle, J & Mcnamara, M 2020, 'NET-02 trial protocol : A multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC)', BMJ Open, vol. 10, no. 2, e034527, pp. e034527. https://doi.org/10.1136/bmjopen-2019-034527
Témata: Neuroendocrine carcinoma, randomised, single-stage, liposomal irinotecan, docetaxel, Humans, Irinotecan/therapeutic use, Randomized Controlled Trials as Topic, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Docetaxel/therapeutic use, Fluorouracil/therapeutic use, Multicenter Studies as Topic, Carcinoma, Neuroendocrine/drug therapy, Quality of Life, Clinical Trials, Phase II as Topic, Leucovorin/therapeutic use, ResearchInstitutes_Networks_Beacons/mcrc, name=Manchester Cancer Research Centre
Full Text Finder 
Nájsť tento článok vo Web of Science 
Full Text